Announcements on 31 jan provided zero enthusiasm and accordingly the share price is going lower. Raised capital at 5c in June last year, now near 20% lower. Information coming through is same same -nothing groundbreaking in terms income, approvals or effectivenss of the treatments.
Ann: Two key treatment centres treat first patients with OncoSil, page-4
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $23.78M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $34.37K | 5.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4929003 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 23400459 | 26 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |